Stella ChemifaSTELLA CHEMIFA CORPORATION4109東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥12 is left as operating profit. Revenue changed +1.4% from the prior year, operating profit +7.1%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 14.4% | 0.66× | 9.5% | 1.37× | 12.9% |
| 2023 | 6.4% | 0.63× | 4.1% | 1.35× | 5.5% |
| 2024 | 6.1% | 0.53× | 3.2% | 1.36× | 4.4% |
| 2025 | 8.0% | 0.61× | 4.8% | 1.41× | 6.9% |
| 2026 | 8.3% | 0.59× | 4.9% | 1.43× | 7.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 37,296 | 35,382 | 30,446 | 36,288 | 36,799 |
| Cost of revenue | 28,394 | 27,972 | 23,999 | 28,031 | 28,218 |
| Gross profit | 8,902 | 7,410 | 6,446 | 8,257 | 8,581 |
| SG&A | 4,318 | 3,896 | 3,724 | 3,918 | 3,936 |
| Operating income | 4,583 | 3,514 | 2,722 | 4,338 | 4,644 |
| Pretax income | 6,840 | 3,366 | 2,613 | 4,224 | 4,395 |
| Income tax | 1,814 | 1,383 | 777 | 1,352 | 1,348 |
| Net income attributable to owners | 5,364 | 2,280 | 1,845 | 2,892 | 3,058 |
| Operating margin | 12.3% | 9.9% | 8.9% | 12.0% | 12.6% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥15.5B | ¥14.7B | ¥15.8B | ¥16.2B | ¥14.3B |
| Total assets | ¥56.6B | ¥55.5B | ¥58.6B | ¥60.7B | ¥64.1B |
| Net assets | ¥42.7B | ¥43.2B | ¥44.5B | ¥45B | ¥48.1B |
| Share capital | ¥4.83B | ¥4.83B | ¥4.83B | ¥4.83B | ¥4.83B |
| Property, plant and equipment | ¥21.7B | ¥22.6B | ¥25.4B | ¥26.7B | ¥28.4B |
| Intangible assets excluding goodwill | ¥375M | ¥261M | ¥149M | ¥42M | ¥69M |
| Investment securities | ¥3.21B | ¥3.06B | ¥3.02B | ¥3.16B | ¥5.59B |
| Current assets | ¥30.6B | ¥28.6B | ¥29B | ¥29.8B | ¥28.9B |
| Current liabilities | ¥9.8B | ¥8.89B | ¥8.89B | ¥9.78B | ¥9.09B |
| Trade payables | ¥1.74B | ¥1.47B | ¥1.28B | — | — |
| Short-term borrowings | ¥1.92B | ¥1.92B | ¥2B | ¥2B | ¥1.6B |
| Long-term borrowings | ¥2B | ¥1.07B | ¥1.95B | ¥2.42B | ¥2.87B |
| Total liabilities | ¥13.9B | ¥12.3B | ¥14.1B | ¥15.7B | ¥16.1B |
| Non-controlling interests | ¥508M | ¥238M | ¥240M | ¥240M | ¥236M |
| Equity attributable to owners of parent | ¥41.4B | ¥41.5B | ¥42.3B | ¥42.1B | ¥45.2B |
| Retained earnings | ¥29.4B | ¥30.9B | ¥31.7B | ¥31.7B | ¥32.8B |
| Treasury stock | -¥1.64B | -¥2.99B | -¥2.96B | -¥3.27B | -¥2.15B |
EDINET (FSA Japan)
有価証券報告書－第83期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第82期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第81期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第80期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第79期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第78期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 52 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.